Innovation and Product Focus Intact Vascular specializes in minimally invasive peripheral vascular products, including the Tack Endovascular System, providing physicians with advanced treatment options for peripheral artery disease and creating opportunities to introduce innovative vascular solutions.

Strategic Acquisition Footprint Being acquired by Philips and integrated into its image-guided therapy portfolio positions Intact Vascular within a broader ecosystem, offering sales opportunities through partnerships in advanced medical imaging and minimally invasive devices.

Market Entry and Adoption Having launched the Tack Endovascular System in the US with peer-reviewed clinical validation, there is potential to expand usage across additional markets and healthcare institutions seeking proven minimally invasive therapies.

Funding and Growth Potential With recent funding of $25 million and a focused development pipeline, the company is positioned for rapid growth and product expansion, presenting opportunities for sales partnerships and distribution channels.

Target Customer Profile Intact Vascular’s primary customers include vascular specialists and hospital systems investing in advanced device solutions for vascular disease, providing a clear target for direct sales, education, and aligned service offerings.